Ask AI
ProCE Banner Activity

TKIs for Advanced HCC in the Second Line and Beyond

Podcast Episodes
In this podcast episode, experts Josep M. Llovet, MD, PhD, and Univ. Prof. Markus Peck-Radosavljevic, MD, MBA, discuss the role of tyrosine kinase inhibitors in treating patients with advanced HCC in the second line and beyond.

Released: February 22, 2022

Expiration: February 21, 2023

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma